echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Indomethacin, meloxicam, celecoxib... how to choose non-steroidal anti-inflammatory drugs for AS

    Indomethacin, meloxicam, celecoxib... how to choose non-steroidal anti-inflammatory drugs for AS

    • Last Update: 2022-01-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The "inflammation" in ankylosing spondylitis (AS) is part of the body's innate immune system (the first line of defense against disease and injury), but if the inflammatory response persists for too long, it can lead to a condition called Diseases of chronic inflammation (in which the body attacks itself, causing damage to organs and systems), typically with redness, swelling, heat, pain, and dysfunction


    Ankylosing spondylitis The "inflammation" in ankylosing spondylitis (AS) is part of the body's innate immune system (the first line of defense against disease and injury), but if the inflammatory response persists for too long, it can lead to a A condition called chronic inflammation (in which the body attacks itself, causing damage to organs and systems), is typically characterized by redness, swelling, heat, pain, and dysfunction


    What are NSAIDs?

    Steroids generally refer to steroids (hormones as we understand them), while nonsteroidal anti-inflammatory drugs (NSAIDs) refer to non-hormonal anti-inflammatory drugs


    Steroids generally refer to steroids (hormones as we understand them), while nonsteroidal anti-inflammatory drugs (NSAIDs) refer to non-hormonal anti-inflammatory drugs


    Aspirin, indomethacin, naproxen, ibuprofen, diclofenac, loxoprofen, meloxicam, celecoxib, etoricoxib, and parecoxib are all non-steroidal body anti-inflammatory drugs


    What is the role of NSAIDs in ankylosing spondylitis?

    The common inflammatory mediators in patients with ankylosing spondylitis include prostaglandins, interleukins, and tumor necrosis factor , etc.


    The common inflammatory mediators in patients with ankylosing spondylitis include prostaglandins, interleukins, and tumor necrosis factor , etc.


    It should be noted, however , that ankylosing spondylitis also has a distinctive feature - new bone formation


    But it is important to note that there is also a significant feature of ankylosing spondylitis - new bone formation


     

    Because of the limited effect of non-steroidal anti-inflammatory drugs on the control of deep inflammation in the joint cavity, it is "powerless" to local soft tissue adhesion, so it is difficult to prevent the formation of osteophytes.


    Because of the limited effect of non-steroidal anti-inflammatory drugs on the control of deep inflammation in the joint cavity, it is "powerless" to local soft tissue adhesion, so it is difficult to prevent the formation of osteophytes.


    Like any other drug, non-steroidal anti-inflammatory drugs can produce some adverse reactions when used for a long time


    01 Gastrointestinal 01 Gastrointestinal

    Abdominal discomfort, dull pain , nausea, vomiting, fullness, belching, loss of appetite and other indigestion symptoms may occur


    Abdominal discomfort, dull pain , nausea, vomiting, fullness, belching, loss of appetite and other indigestion symptoms may occur


    02 Liver02 Liver

    At therapeutic doses, 10% of patients developed biochemical abnormalities with mild liver damage, but significantly elevated alanine aminotransferase levels occurred in less than 2%


    At therapeutic doses, 10% of patients developed biochemical abnormalities with mild liver damage, but significantly elevated alanine aminotransferase levels occurred in less than 2%


    03 Nervous System03 Nervous System

    Headache, dizziness, tinnitus, deafness, amblyopia, drowsiness, insomnia, paresthesia, numbness, etc.
    may occur
    .
    Some symptoms are uncommon, such as hyperactivity, excitement, hallucinations, tremors, etc.
    , the incidence is generally less than 5%
    .

    Headache, dizziness, tinnitus, deafness, amblyopia, drowsiness, insomnia, paresthesia, numbness, etc.
    may occur
    .
    Some symptoms are uncommon, such as hyperactivity, excitement, hallucinations, tremors, etc.
    , the incidence is generally less than 5%
    .

    04Urinary system

    04Urinary System04Urinary System

    It can cause proteinuria, cast urine, red and white blood cells, etc.
    in the urine.
    In severe cases, it can cause interstitial nephritis
    .
    In a multicenter clinical study, patients taking long-term oral NSAIDs had a 2.
    1 -fold higher risk of developing kidney disease than the general population
    .

    It can cause proteinuria, cast urine, red and white blood cells, etc.
    in the urine.
    In severe cases, it can cause interstitial nephritis
    .
    In a multicenter clinical study, patients taking long-term oral NSAIDs had a 2.
    1 -fold higher risk of developing kidney disease than the general population
    .
    2.
    1

    05Blood system

    05Blood system05Blood system

    Some NSAIDs can cause neutropenia, aplastic anemia, and coagulation disorders
    .

    Some NSAIDs can cause neutropenia, aplastic anemia, and coagulation disorders
    .

    06 Allergies

    06Allergies06Allergies _

    Idiopathic people may have allergic reactions such as rash, angioedema , and asthma
    .

    Idiopathic people may have allergic reactions such as rash, angioedema , and asthma
    .
    Blood vessel

    07 Cardiovascular System

    07Cardiovascular System07Cardiovascular System

    Studies have found that NSAIDs can significantly interfere with blood pressure and increase mean arterial pressure
    .
    It has also been reported that after taking rofecoxib for 18 months, the relative risk of cardiovascular events (such as heart attack and stroke) increased in patients
    .

    Studies have found that NSAIDs can significantly interfere with blood pressure and increase mean arterial pressure
    .
    It has also been reported that after taking rofecoxib for 18 months, the relative risk of cardiovascular events (such as heart attack and stroke) increased in patients
    .
    cardiovascular events

    08 Pregnancy

    08 Pregnancy 08 Pregnancy

    Non-steroidal anti-inflammatory drugs are considered to be a potential factor in the induction of acute fatty liver of pregnancy ; aspirin in pregnant women can cause bleeding during prenatal, postpartum, and delivery; indomethacin may cause some fetal brachymorphs , penile hypoplasia .

    Non-steroidal anti-inflammatory drugs are considered to be a potential factor in the induction of acute fatty liver of pregnancy ; aspirin in pregnant women can cause bleeding during prenatal, postpartum, and delivery; indomethacin may cause some fetal brachymorphs , penile hypoplasia .

    Induced acute fatty liver of pregnancy in pregnant women aspirin indomethacin may cause some fetal short limb deformities How to reduce the incidence of side effects?

    ① In clinical application, the combined use of two or more NSAIDs should be avoided
    .

    ① In clinical application, the combined use of two or more NSAIDs should be avoided
    .
    Avoid combining two or more NSAIDs

    ② For patients with gastrointestinal discomfort or peptic ulcer , COX-2 inhibitors are preferred over traditional non-steroidal anti-inflammatory drugs, and gastric drugs should be added if necessary
    .

    ② For patients with gastrointestinal discomfort or peptic ulcer , COX-2 inhibitors are preferred over traditional non-steroidal anti-inflammatory drugs, and gastric drugs should be added if necessary
    .
    For patients with gastrointestinal discomfort or peptic ulcer, COX-2 inhibitors are preferred , and gastric drugs should be added if necessary

    ③ For patients with only high cardiovascular risk and no other risk factors, consider the priority use of naproxen
    .

    ③ For patients with only high cardiovascular risk and no other risk factors, consider the priority use of naproxen
    .
    Cardiovascular high-risk naproxen only
    .

    ④ While using non-steroidal anti-inflammatory drugs, if the situation allows, avoid the use of diuretics , ACEI/ARB antihypertensive drugs and other drugs that may affect renal perfusion at the same time
    .

    ④ While using non-steroidal anti-inflammatory drugs, if the situation allows, avoid the use of diuretics , ACEI/ARB antihypertensive drugs and other drugs that may affect renal perfusion at the same time
    .

    avoid diuretics

    ⑤ NSAIDs have a capping effect, and overdose should be avoided
    .
    Overdose, the efficacy does not increase, but the side effects will increase significantly
    .

    ⑤ NSAIDs have a capping effect, and overdose should be avoided
    .
    Overdose, the efficacy does not increase, but the side effects will increase significantly
    .
    Overdose should be avoided

    ⑥ Necessary blood and renal function monitoring should be carried out regularly under the guidance of a doctor
    .

    ⑥ Necessary blood and renal function monitoring should be carried out regularly under the guidance of a doctor
    .


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.